Concepedia

Shude Cui

SC

29

Publications

1.5K

Citations

19

H-Index

2011

Active since

Affiliations

Henan Cancer Hospital(Current)

Harbin Medical University

Jilin University

First Hospital of Jilin University

Zhengzhou University

Shude Cui is an author at Henan Cancer Hospital specializing in breast cancer, medicine, and oncology.

Top concepts

Publications per year

2011–2023

29

Publications

29

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Zefei Jiang, Wei Li, Xichun Hu et al. · The Lancet Oncology · 2019 · 261 citations

, , +8

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia

Zhimin Shao, Da Pang, Hongjian Yang et al. · JAMA Oncology · 2019 · 184 citations · Full text

A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy

Qin Li, CHENG-ZHENG WANG, Huijie Fan et al. · Oncology Letters · 2014 · 103 citations · Full text

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 103 citations · Full text

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Peng Yuan, Xichun Hu, Tao Sun et al. · European Journal of Cancer · 2019 · 86 citations

Rows per page

1–5 of 29